These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 26521446)
1. [Design, synthesis and biological evaluation of novel 3-(2-oxo-2-substituted acetamido)benzamides as PARP-1 inhibitors]. Yin YW; Ji M; Cao R; Chen XG; Xu BL Yao Xue Xue Bao; 2015 Jun; 50(6):738-45. PubMed ID: 26521446 [TBL] [Abstract][Full Text] [Related]
2. [Design, synthesis and biological evaluation of novel para-substituted 1-benzyl-quinazoline-2, 4 (1H, 3H)-diones as human PARP-1 inhibitors]. Yao HP; Zhu ZX; Ji M; Chen XG; Xu BL Yao Xue Xue Bao; 2014 Apr; 49(4):497-503. PubMed ID: 24974467 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, biological evaluation and molecular docking study of novel urea-based benzamide derivatives as potent poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Lu G; Nie W; Xin M; Meng Y; Gu J; Miao H; Cheng X; Chan ASC; Zou Y Eur J Med Chem; 2022 Dec; 243():114790. PubMed ID: 36183505 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and anticancer activities of novel dual poly(ADP-ribose) polymerase-1/histone deacetylase-1 inhibitors. Tian Y; Xie Z; Liao C Bioorg Med Chem Lett; 2020 Apr; 30(8):127036. PubMed ID: 32088129 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel PARP-1 inhibitors: Drug design, synthesis and biological evaluation. Xie Z; Zhou Y; Zhao W; Jiao H; Chen Y; Yang Y; Li Z Bioorg Med Chem Lett; 2015 Oct; 25(20):4557-61. PubMed ID: 26342868 [TBL] [Abstract][Full Text] [Related]
6. Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors. Chadha N; Jaggi AS; Silakari O Mol Divers; 2017 Aug; 21(3):655-660. PubMed ID: 28653128 [TBL] [Abstract][Full Text] [Related]
7. Discovery of quinazoline-2,4(1H,3H)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity. Zhou J; Ji M; Yao H; Cao R; Zhao H; Wang X; Chen X; Xu B Org Biomol Chem; 2018 May; 16(17):3189-3202. PubMed ID: 29648554 [TBL] [Abstract][Full Text] [Related]
8. Discovery of 2-(1-(3-(4-Chloroxyphenyl)-3-oxo- propyl)pyrrolidine-3-yl)-1 Min R; Wu W; Wang M; Tang L; Chen D; Zhao H; Zhang C; Jiang Y Molecules; 2019 May; 24(10):. PubMed ID: 31108884 [TBL] [Abstract][Full Text] [Related]
9. Novel tricyclic poly (ADP-ribose) polymerase-1/2 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis and biological evaluation. Li H; Hu Y; Wang X; He G; Xu Y; Zhu Q Bioorg Med Chem; 2016 Oct; 24(19):4731-4740. PubMed ID: 27561983 [TBL] [Abstract][Full Text] [Related]
10. Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors. Yao H; Ji M; Zhu Z; Zhou J; Cao R; Chen X; Xu B Bioorg Med Chem; 2015 Feb; 23(4):681-93. PubMed ID: 25614115 [TBL] [Abstract][Full Text] [Related]
11. Design and Synthesis of Poly(ADP-ribose) Polymerase Inhibitors: Impact of Adenosine Pocket-Binding Motif Appendage to the 3-Oxo-2,3-dihydrobenzofuran-7-carboxamide on Potency and Selectivity. Velagapudi UK; Langelier MF; Delgado-Martin C; Diolaiti ME; Bakker S; Ashworth A; Patel BA; Shao X; Pascal JM; Talele TT J Med Chem; 2019 Jun; 62(11):5330-5357. PubMed ID: 31042381 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological activity of novel molecules designed to target PARP and DNA. Goodfellow E; Senhaji Mouhri Z; Williams C; Jean-Claude BJ Bioorg Med Chem Lett; 2017 Feb; 27(3):688-694. PubMed ID: 28003142 [TBL] [Abstract][Full Text] [Related]
13. Contrasting sirtuin and poly(ADP-ribose)polymerase activities of selected 2,4,6-trisubstituted benzimidazoles. Yeong KY; Tan SC; Mai CW; Leong CO; Chung FF; Lee YK; Chee CF; Abdul Rahman N Chem Biol Drug Des; 2018 Jan; 91(1):213-219. PubMed ID: 28719017 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel molecules as potent PARP-1 inhibitors. Shen H; Ge Y; Wang J; Li H; Xu Y; Zhu Q Bioorg Med Chem Lett; 2021 Sep; 47():128169. PubMed ID: 34091044 [TBL] [Abstract][Full Text] [Related]
15. In silico investigation of PARP-1 catalytic domains in holo and apo states for the design of high-affinity PARP-1 inhibitors. Salmas RE; Unlu A; Yurtsever M; Noskov SY; Durdagi S J Enzyme Inhib Med Chem; 2016; 31(1):112-20. PubMed ID: 26083304 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel PARP-1 inhibitors based on pyridopyridazinone scaffold. Elmasry GF; Aly EE; Awadallah FM; El-Moghazy SM Bioorg Chem; 2019 Jun; 87():655-666. PubMed ID: 30952061 [TBL] [Abstract][Full Text] [Related]
17. Multiple receptor conformation docking, dock pose clustering and 3D QSAR studies on human poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Fatima S; Jatavath MB; Bathini R; Sivan SK; Manga V J Recept Signal Transduct Res; 2014 Oct; 34(5):417-30. PubMed ID: 25046176 [TBL] [Abstract][Full Text] [Related]
18. Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer. Zhu Q; Wang X; Hu Y; He X; Gong G; Xu Y Bioorg Med Chem; 2015 Oct; 23(20):6551-9. PubMed ID: 26422786 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors. Chen X; Huan X; Liu Q; Wang Y; He Q; Tan C; Chen Y; Ding J; Xu Y; Miao Z; Yang C Eur J Med Chem; 2018 Feb; 145():389-403. PubMed ID: 29335205 [TBL] [Abstract][Full Text] [Related]
20. 1-Oxo-3,4-dihydroisoquinoline-4-carboxamides as novel druglike inhibitors of poly(ADP-ribose) polymerase (PARP) with favourable ADME characteristics. Safrygin A; Zhmurov P; Dar'in D; Silonov S; Kasatkina M; Zonis Y; Gureev M; Krasavin M J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1968-1983. PubMed ID: 34482781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]